Clinical Trial Update: TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase II trial update for Olaparib (TOPARP) in advanced castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Adenocarcinoma of the Prostate | Phase 2 | Status: UNKNOWN